The following represents disclosure information provided by authors of this abstract. The Genitourinary Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Molecular profiling of infiltrating urothelial carcinoma of the bladder.
Sherri Z. Millis
Employment or Leadership Position - Caris Life Sciences
David Bryant
Employment or Leadership Position - Caris Life Sciences
Stock Ownership - Caris Life Sciences
Gargi Dan Basu
Employment or Leadership Position - Caris Life Sciences
Stock Ownership - Caris Life Sciences
Ryan Bender
Employment or Leadership Position - Caris Life Sciences
Stock Ownership - Caris Life Sciences
Semir Vranic
No relevant relationships to disclose
Zoran Gatalica
Employment or Leadership Position - Caris Life Sciences
Stock Ownership - Caris Life Sciences
Nicholas J. Vogelzang
Honoraria - Caris Life Sciences